No guarantee of funding for new medicines funding – which is being squeezed again
Platform combines morphology analysis, cell counting and cell classification.
Trump focused on reforming or repealing Obamacare
Pharma marketers have to focus on benefitting patients, not return on investment.
Proactive and included patients can help clinical trial retention.
A new way to capture when drugs are ‘cost effective’ but not ‘affordable’ looks set to be introduced in England.
02/11/2016November 1, 2016
22/11/2016October 20, 2016
08/12/2016October 18, 2016
A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.